A career devoted to research
Dr Richard E. Frye
Over 20 years of research to better understand autism
Pediatric neurologist · Researcher · Scientific advisor to Neuro+
For more than twenty years, Dr Richard E. Frye has devoted much of his career to better understanding autism and neurodevelopmental disorders.
An American physician and researcher, and the author of many scientific publications, he studies the biological mechanisms associated with autism and new avenues of research, with a deeply human goal: helping to improve the lives of children and their families.
Today, he also supports Neuro+ as a scientific advisor and partner.
An outstanding medical and scientific career
Dr Frye holds a medical degree (MD) and a doctorate in physiology and biophysics (PhD) from Georgetown University in the United States.
He completed his training in pediatric neurology at Boston Children’s Hospital, affiliated with Harvard University, before specializing further in learning and developmental disorders.
Over the course of his career, he has led several clinical and research programs dedicated to autism, notably at the Arkansas Children’s Research Institute and Phoenix Children’s Hospital.
This path has allowed him to combine two essential dimensions: hands-on experience with children and their families, and scientific research aimed at better understanding their individual characteristics.
Advancing the understanding of autism
Autism is a complex field in which many scientific questions remain open.
Dr Frye has devoted a significant part of his research to certain biological mechanisms associated with autism, in particular the functioning of mitochondria, which produce much of the cells’ energy, and folate metabolism.
His work, published in many international scientific journals, has helped broaden knowledge of the diversity of biological profiles found in autistic people.
He advocates an approach that pays close attention to individual differences, in which research makes it possible to explore new avenues and better understand each child’s needs.
A commitment that goes beyond research
For Dr Frye, research is not limited to laboratories and publications. It is also driven by the questions families ask themselves every day.
In 2022, he co-founded the Autism Discovery and Treatment Foundation², an American nonprofit organization dedicated to research on autism and complex neurodevelopmental disorders.
He continues his commitment to advancing scientific knowledge and exploring new possibilities for future generations.
A commitment to families
“I want to offer hope to families raising children who have challenging neurodevelopmental disorders.”
Dr Richard E. Frye ¹
A researcher also involved in the study of photobiomodulation
Among the scientific fields he is interested in is transcranial photobiomodulation, a technology that uses red or near-infrared light and whose applications to the brain are currently being researched.
Dr Frye has notably served as principal investigator of an exploratory clinical study in the United States³ on photobiomodulation in autistic children with certain neurological characteristics.
His interest in this field reflects his commitment to continue exploring emerging scientific approaches while contributing to their evaluation.
To learn more about the technology, visit our page on photobiomodulation.
Near-infrared light is being studied for various applications, including transcranial photobiomodulation.
Dr Frye alongside Neuro+
At Neuro+, we are fortunate to count Dr Richard Frye among our partners and scientific advisors.
His involvement goes well beyond a simple advisory role.
Drawing on his experience with autistic children and his many years of research, he works directly with our team and shares his recommendations to help us keep improving our program.
In particular, his expertise helps us refine our usage protocols, with special attention to differences in sensitivity and to each child’s specific needs.
This collaboration reflects our conviction: photobiomodulation deserves a thoughtful, personalized approach that stays open to new scientific knowledge.
That is also the spirit in which we designed Neuro+: a program that combines a photobiomodulation helmet prepared for each child with genuine human support, to guide families throughout their experience.
Dr Richard E. Frye is a scientific advisor to Neuro+ and holds an equity stake in the company.
The Neuro+ team, supporting families every day.
Learn more
Official sources
¹ Biography and career: Official website of Dr Richard E. Frye, MD, PhD.
² Nonprofit work: Autism Discovery and Treatment Foundation.
³ Photobiomodulation research: ClinicalTrials.gov, NCT06352372.